Suppr超能文献

竖脊肌平面阻滞对乳腺手术后患者的镇痛效果:系统评价和荟萃分析。

Analgesic effects of erector spinae plane block for patients after breast surgery: a systematic review and meta-analysis.

机构信息

Department of Gynecology, Tongxiang Maternal And Child Health Care Hospital, Tongxiang, Zhejiang, China.

Department of Anesthesiology, Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, China; The First Hospital of Jiaxing.

出版信息

J Int Med Res. 2021 Mar;49(3):300060521999568. doi: 10.1177/0300060521999568.

Abstract

OBJECTIVE

This meta-analysis investigated the analgesic effects of erector spinae plane block (ESPB) in patients undergoing breast surgery.

METHODS

PubMed, Embase, Web of Science, and the Cochrane Library were searched from database establishment to January 31, 2020. Two reviewers independently extracted the data. The primary outcomes were pain scores and opioid consumption during the first 24 hours after surgery. The risk of bias of the included studies was assessed according to the Cochrane Handbook.

RESULTS

Six randomized controlled trials of 415 patients were included. Compared with the control value, the pain score was significantly lower in the ESPB group at different time points postoperatively. Patients who underwent ESPB required lower opioid consumption (standardized mean difference = -2.02, 95% confidence interval [CI] = -2.85 to -1.20, = 91%. The rates of postoperative nausea (risk ratio [RR] = 0.79, 95% CI = 0.48-1.30,  = 47%) and postoperative vomiting (RR = 0.76, 95% CI = 0.30-1.96,  = 33%) did not differ between the groups. The quality of evidence was low or very low.

CONCLUSIONS

ESPB significantly alleviated pain and reduced opioid consumption after breast surgery. Further research is needed to expand its clinical application.PROSPERO registration number CRD42020167900.

摘要

目的

本荟萃分析旨在探讨竖脊肌平面阻滞(ESPB)在乳房手术后患者中的镇痛效果。

方法

从数据库建立到 2020 年 1 月 31 日,检索了 PubMed、Embase、Web of Science 和 Cochrane 图书馆。两位审查员独立提取数据。主要结局指标为术后 24 小时内的疼痛评分和阿片类药物消耗。根据 Cochrane 手册评估纳入研究的偏倚风险。

结果

纳入了 6 项涉及 415 例患者的随机对照试验。与对照组相比,ESPB 组在术后不同时间点的疼痛评分均显著降低。接受 ESPB 的患者需要较少的阿片类药物消耗(标准化均数差 = -2.02,95%置信区间[CI] = -2.85 至 -1.20, = 91%)。术后恶心(风险比[RR] = 0.79,95% CI = 0.48-1.30,  = 47%)和呕吐(RR = 0.76,95% CI = 0.30-1.96,  = 33%)的发生率在两组之间无差异。证据质量为低或极低。

结论

ESPB 显著减轻了乳房手术后的疼痛并减少了阿片类药物的消耗。需要进一步的研究来扩大其临床应用。PROSPERO 注册号 CRD42020167900。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验